Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Efficacy Of RSV Vaccine Held Strong For At Least Two RSV Seasons In Older Adults, Study Finds

    MedPage Today (10/15, Susman) reports, “Efficacy of the...respiratory syncytial virus (RSV) vaccine held strong for at least two RSV seasons in older adults, according to the AReSVi-006 study.” Investigators found that “the RSV perfusion F protein vaccine...
    Full Article
  • Researchers Say AI Model May Help Predict Future Virus Evolution

    Health IT Analytics (10/13, Kennedy) reported researchers “have developed an artificial intelligence tool capable of predicting how a virus could evolve to escape the immune system, according to a study” published in Nature. The model “leverages biologica...
    Full Article
  • Early Signs Show Spread Of Flu, COVID-19, RSV Nationwide

    NBC News (10/13, Edwards) said, “Flu cases are low nationwide, the Centers for Disease Control and Prevention reported Friday, but there are early signs that the virus is beginning to spread.” Flu, COVID-19, and RSV “are likely to circulate this winter,”...
    Full Article
  • More Than 7M Americans Have Received Updated COVID-19 Vaccines, HHS Data Indicate

    Reuters (10/12, Wingrove) reports that a month after their approval, “more than 7 million Americans had rolled up their sleeves for the updated COVID-19 vaccines as of Wednesday, according to the U.S. Department of Health and Human Services, despite repor...
    Full Article
  • Acinetobacter Baumannii, Candida Auris Common Among Patients Receiving Mechanical Ventilation, Data Indicate

    MedPage Today (10/12, Susman) reports, “Acinetobacter baumannii and Candida auris were common among patients receiving mechanical ventilation in both acute care hospitals and long-term care facilities, particularly the latter, according to data from the M...
    Full Article
  • Barriers Hinder PrEP Uptake Among Cisgender Black Women, Experts Say

    Kaiser Health News (10/12, Whitehead) reports that “more than a decade after the first PrEP drug was approved for the U.S. market, one of the groups that would benefit most from the medications isn’t taking them: Black women...whose gender identity align...
    Full Article
  • Daily Oral PrEP Has Highest Preference Ranking Among Young Men Who Have Sex With Men, Study Says

    HealthDay (10/12, Gotkine) reports, “Daily oral preexposure prophylaxis (PrEP) has the highest preference ranking among young men who have sex with men, according to” a study published in the Journal of the International AIDS Society. Investigators “found...
    Full Article
  • Universal Decolonization In Nursing Homes Reduced Risk Of Infection-Related Hospitalizations, Research Shows

    According to MedPage Today (10/12, Ingram), “Universal decolonization in nursing homes – by way of a chlorhexidine wash during routine bathing paired with a nasal antiseptic – reduced the risk of infection-related hospitalizations,” findings from “a clust...
    Full Article
  • COVID-19 mRNA Booster Vaccine Provided Additional Protection During Delta, Omicron Waves, Data Show

    Healio (10/12, Stulpin) reports, “Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at” IDW...
    Full Article
  • Data Demonstrate Utility Of Fostamatinib For Reducing Mortality, Morbidity In People Hospitalized With COVID-19 Requiring Oxygen

    Drug Topics (10/12, Bigica) reports, “Data presented at IDWeek 2023 demonstrates the utility of added fostamatinib to standard of care for reducing mortality and morbidity among people hospitalized with COVID-19 who require oxygen supplementation.” Overal...
    Full Article
  • Building Bridges to Elevate the Laboratory: ASCP’s Support of the CDC’s OneLab Initiative

    Abstract Not Available
    Full Article
  • Laboratory Strategies to Improve Allergy First-Line Screening in Primary Care

    Abstract Not Available
    Full Article
  • How I diagnose myeloid neoplasms with germline predisposition

    Abstract Not Available
    Full Article
  • Critical Update for Hispanic/Latinx Heritage Month and Indigenous Peoples’ Day

    Abstract Not Available
    Full Article
  • Biden Administration Aims To Cut Sepsis Deaths By Tying Medicare Payments To Treatment Metrics

    KFF Health News (10/11, Appleby) reports delays in the treatment of sepsis “of even a few hours can undermine a patient’s chance of survival,” but the infection “can be difficult to diagnose because some patients don’t present with common symptoms like fe...
    Full Article
  • More Blood Tests To Diagnose Alzheimer’s Needed, Experts Say

    Reuters (10/11, Beasley) reports, “Blood tests for Alzheimer’s are needed to more widely diagnose the brain-wasting disease and understand its prevalence, but it will be another couple of years before they become an everyday tool, medical experts and comp...
    Full Article
  • Intranasal COVID-19 Vaccine Shows Promise In Early Testing

    HealthDay (10/11, Murez) reports, “New research points to the potential of a COVID-19 vaccine delivered through the nose.” An early-stage study “showed that the product, administered nasally in two doses, delivered a significant immune response to multipl...
    Full Article
  • Adding Dexamethasone To Treatment For TB Meningitis Among Patients With Advanced HIV Did Not Significantly Improve Survival, Trial Shows

    MedPage Today (10/11, Haelle) reports, “Adding dexamethasone to treatment for tuberculous (TB) meningitis among heavily immunosuppressed HIV-positive patients in a low-resource setting did not significantly improve survival or confer any other measured be...
    Full Article
  • Cost, Insurance Reimbursement Complicating Rollout Of RSV Antibody

    CBS News (10/11, Brand, M. Moniuszko) reports, “The CDC and FDA have approved the Beyfortus antibody shot, from drugmakers AstraZeneca and Sanofi, to prevent respiratory syncytial virus in babies from birth to 8 months old, or in children up to 24 months...
    Full Article
  • EU, Gates Foundation Announce New Financing Package To Eradicate Polio

    Reuters (10/11, Payne, Rigby) reports, “The European Union together with the Bill & Melinda Gates Foundation and the European Investment Bank have announced a new financing package of more than 1 billion euros ($1.06 billion) to eradicate polio, the EU an...
    Full Article
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id